logo
Dropping COVID shots from vax schedule causes uproar

Dropping COVID shots from vax schedule causes uproar

Axios5 days ago

Health Secretary Robert F. Kennedy Jr.'s decision to stop recommending COVID-19 vaccines for healthy children and healthy pregnant women continued a pattern of breaking with scientific precedent and leaving big segments of the medical community angry and confused.
Why it matters: The announcement on Tuesday offered more indications that Kennedy could be going back on a pledge he made during his Senate confirmation hearings not to make vaccination more difficult or discourage people from taking vaccines.
It also left key questions unanswered. For example, federal health officials last week cited pregnancy as a risk factor for developing severe COVID-19 when they announced steps to limit the shots to seniors and people with conditions that put them at higher risk of serious infections.
Some young children who have not yet had a COVID vaccine will now likely not be covered and be at greater risk of being exposed to possible long-term effects of the virus, said Molly O'Shea, a board-certified pediatrician and member of the American Academy of Pediatrics.
Michael Osterholm, director of the University of Minnesota's Center for Infectious Disease Research and Policy, said dialing back the vaccine recommendation was another example of "on the fly" policymaking without consultation or new information that's become a hallmark of Kennedy's tenure.
Driving the news: The decision came on the heels of last week's overhaul of COVID-19 vaccine standards that will require drugmakers to conduct more studies on the safety and efficacy of updated boosters for healthy adults under age 65.
In a video posted to social media on Tuesday, Kennedy blamed the Biden administration for encouraging healthy children to get updated COVID shots "despite the lack of any clinical data to support the repeat booster strategy in children."
"We're now one step closer to realizing President Trump's promise to make America healthy again," Kennedy said.
Between the lines: The move has ramifications for insurance coverage, since health plans often look to Centers for Disease Control and Prevention expert recommendations to guide their payment decisions.
"This decision could make it significantly harder for millions of Americans to access vaccines they want for themselves and their families," Tina Tan, president of the Infectious Diseases Society of America, said in a statement.
Dropping the recommendations also breaks with the precedent of letting federal panels of experts publicly debate scientific evidence and vote on immunization practices. The CDC's Advisory Committee on Immunization Practices, or ACIP, typically makes vaccine recommendations to the agency director, a post that's currently vacant.
"It is concerning that such a significant policy change was made unilaterally outside an open, evidence-based process with no regard for the negative impact this will have on millions of Americans," Tan said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19
Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19

Business Insider

timean hour ago

  • Business Insider

Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19

Moderna (MRNA) announced that the U.S. Food and Drug Administration, FDA, has approved mNEXSPIKE, a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention. 'The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,' said Stephane Bancel, Chief Executive Officer of Moderna. 'COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health.' Confident Investing Starts Here:

FDA approves Moderna's new lower-dose Covid-19 vaccine
FDA approves Moderna's new lower-dose Covid-19 vaccine

CNBC

time5 hours ago

  • CNBC

FDA approves Moderna's new lower-dose Covid-19 vaccine

The U.S. approved a new Covid-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current Covid-19 vaccine, Spikevax — by refining its immune target. The approval "adds an important new tool to help protect people at high risk of severe disease from Covid-19," Stephane Bancel, Moderna's CEO, said in a statement Saturday. The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus. That's the same limit that the FDA set in licensing another Covid-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled Covid-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials. Moderna's existing vaccine doesn't face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall. The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said. The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results.

‘Absolute Disaster:' Senate Dems Take Aim At Trump's Tax Bill
‘Absolute Disaster:' Senate Dems Take Aim At Trump's Tax Bill

Yahoo

time7 hours ago

  • Yahoo

‘Absolute Disaster:' Senate Dems Take Aim At Trump's Tax Bill

Senate Democrats laid into President Donald Trump's sweeping tax bill on Sunday, emphasizing the impact it is poised to make on millions of Americans on Medicaid. 'This Republican budget bill is an absolute disaster for the country, in particular for middle-class and poor people,' Sen. Chris Murphy (D-CT) said in an interview on CNN's State of the Union, noting that it seeks to pay for tax cuts by curbing spending on social programs. Sen. Raphael Warnock (D-GA) echoed these concerns in an interview on NBC News's Meet the Press, stressing that 'Republicans are trying to push forward this big ugly bill that's going to literally cut as many as seven million Americans off of their healthcare.' Murphy and Warnock's statements come as Republicans' massive tax and spending bill heads to the Senate, where it's likely to face staunch Democratic opposition as well as GOP dissent. The bill slashes spending on social programs like SNAP and Medicaid, while proposing trillions in tax cuts and billions in investments to strengthen border security. According to an initial analysis from the nonpartisan Congressional Budget Office, it would push 7.6 million people off Medicaid, in part by making it more difficult to qualify for the program. One way it does so is by imposing a new work requirement, which would force many able-bodied recipients to prove that they've worked, volunteered or attended a training program to obtain Medicaid coverage. Warnock stressed that a similar policy in Georgia has added new barriers for people in need of healthcare. This 'work reporting requirement is very good at kicking people off of their health care,' he said. 'It's not very good at incentivizing work at all.' Earlier this May, House Republicans narrowly passed the bill by just one vote. It'll take a simple majority – which Republicans have – to advance again in the Senate, though some GOP lawmakers have said they'd like to make changes of their own to tax and Medicaid provisions. GOP Senators like Rick Scott (R-FL) have also raised concerns about how the bill could add to the federal debt, an issue Murphy alluded to as well on Sunday. 'It's just unreal the amount of gaslighting this administration is doing,' Murphy said, while referring to the White House's claims that the legislation won't alter the deficit at all.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store